8,655 Studies Reviewed. 86.9% Found Biological Effects. The Evidence is Clear.
Shield Your Body
Cancer & Tumors

Akbarnejad, M. Esmaeeli, Y, Masoumi-Ardakani, L. Mohammadipoor-Ghasemabad, and H

Bioeffects Seen

Ahmadi-Zeidabadi, M., Z. · 2019

Share:

100 Hz electromagnetic fields at therapeutic intensities enhanced chemotherapy against brain cancer cells, proving EMF creates measurable biological changes at the cellular level.

Plain English Summary

Summary written for general audiences

Researchers exposed human glioblastoma (aggressive brain cancer) cells to a 100 Hz, 100 Gauss extremely low-frequency electromagnetic field while administering the chemotherapy drug Temozolomide. The combined treatment significantly enhanced the drug's anti-cancer effects, reducing cancer stem cell markers by 40-60% and increasing cellular stress indicators. This suggests EMF exposure may overcome drug resistance in brain cancer treatment.

Why This Matters

This study reveals something unexpected: extremely low-frequency electromagnetic fields at 100 Hz actually enhanced chemotherapy effectiveness against aggressive brain cancer cells. Before you interpret this as 'EMF is good for you,' understand the context. The researchers used 100 Gauss, an intensity approximately 2,000 times stronger than typical household exposure (which ranges from 0.5 to 5 milligauss). This isn't your refrigerator's magnetic field. It's a controlled, therapeutic-level exposure in a laboratory setting.

What matters here is the principle: EMF demonstrably alters cellular biology in measurable ways. When scientists apply specific frequencies and intensities, they can influence cancer cell behavior, oxidative stress levels, and calcium signaling. The same biological mechanisms affected in this therapeutic context operate in your cells during everyday EMF exposure, just at different intensities and durations. The difference between medicine and poison is often just the dose. This research proves EMF has real biological effects. The question for you isn't whether EMF affects living cells (it clearly does), but rather what chronic, lower-level exposures mean for healthy tissue over years of cumulative exposure.

Exposure Information

Specific exposure levels were not quantified in this study.

Cite This Study
Ahmadi-Zeidabadi, M., Z. (2019). Akbarnejad, M. Esmaeeli, Y, Masoumi-Ardakani, L. Mohammadipoor-Ghasemabad, and H.
Show BibTeX
@article{akbarnejad_m_esmaeeli_y_masoumi_ardakani_l_mohammadipoor_ghasemabad_and_h_ce3948,
  author = {Ahmadi-Zeidabadi and M. and Z.},
  title = {Akbarnejad, M. Esmaeeli, Y, Masoumi-Ardakani, L. Mohammadipoor-Ghasemabad, and H},
  year = {2019},
  doi = {10.1080/15368378.2019.1625784},
  
}
DOI: 10.1080/15368378.2019.1625784PubMed: 31179753

Quick Questions About This Study

The 100 Gauss (10,000 milligauss) electromagnetic field used in this study was approximately 2,000 times stronger than typical household EMF exposure, which ranges from 0.5 to 5 milligauss near appliances. This was a therapeutic-level intensity designed for laboratory cancer research, not comparable to everyday environmental exposure.
The combined EMF and Temozolomide treatment significantly decreased expression of Nestin, CD133, and Notch4, which are cancer stem cell markers associated with tumor growth and drug resistance. Meanwhile, GFAP (a differentiation marker) increased, suggesting cancer cells were pushed toward a less aggressive, more differentiated state.
Yes, the study found increased superoxide dismutase (SOD) activity and malondialdehyde (MDA) levels, both indicators of oxidative stress. This suggests the EMF exposure created cellular stress conditions that, combined with chemotherapy, enhanced the anti-cancer effect. The treatment also elevated intracellular calcium concentrations, another stress mechanism.
The glioblastoma cells were exposed to the 100 Hz electromagnetic field for either 120 hours (5 days) or 144 hours (6 days) during concurrent Temozolomide treatment. This extended exposure period allowed researchers to observe cumulative effects on cancer cell behavior and gene expression.
While this study proves EMF creates biological effects in brain cells, the therapeutic intensity used was thousands of times stronger than everyday exposure. However, the same cellular mechanisms (calcium signaling, oxidative stress, gene expression changes) operate at lower intensities too, raising legitimate questions about chronic, cumulative exposure effects in healthy tissue.